We found that the GITR+/GFP+ cells exhibited a competitive disadvantage compared to GITR-/GFP+ cells in MM1.S, OPM1 cell lines, indicating that expression of GITR could lead to increased cytotoxicity of MM cells (Figure 3a). The gene discussed is TNFRSF18; the disease is Miyoshi myopathy.